Fixing the Unfixable: The Art of Optimizing Natural Products for Human Medicine
- 26 April 2019
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 62 (18), 8412-8428
- https://doi.org/10.1021/acs.jmedchem.9b00246
Abstract
Molecules isolated from natural sources including bacteria, fungi, and plants are a long-standing source of therapeutics that continue to add to our medicinal arsenal today. Despite their potency and prominence in the clinic, complex natural products often exhibit a number of liabilities that hinder their development as therapeutics, which may be partially responsible for the current trend away from natural product discovery, research, and development. However, advances in synthetic biology and organic synthesis have inspired a new generation of natural product chemists to tackle powerful undeveloped scaffolds. In this Perspective, we will present case studies demonstrating the historical and current focus on making targeted, but significant, changes to natural product scaffolds via biosynthetic gene cluster manipulation, total synthesis, semisynthesis, or a combination of these methods, with a focus on increasing activity, decreasing toxicity, or improving chemical and pharmacological properties.Keywords
Funding Information
- National Science Foundation (1445197)
- U.S. Department of Health and Human Services (R01GM092218)
This publication has 181 references indexed in Scilit:
- Catalytic Site-Selective Thiocarbonylations and Deoxygenations of Vancomycin Reveal Hydroxyl-Dependent Conformational EffectsJournal of the American Chemical Society, 2012
- Synthesis and Characterization of the Arylomycin Lipoglycopeptide Antibiotics and the Crystallographic Analysis of Their Complex with Signal PeptidaseJournal of the American Chemical Society, 2011
- Genetic Interception and Structural Characterization of Thiopeptide Cyclization Precursors from Bacillus cereusJournal of the American Chemical Society, 2010
- Manipulation of Thiocillin Variants by Prepeptide Gene Replacement: Structure, Conformation, and Activity of Heterocycle Substitution MutantsJournal of the American Chemical Society, 2010
- Synthesis of Reblastatin, Autolytimycin, and Non-Benzoquinone Analogues: Potent Inhibitors of Heat Shock Protein 90The Journal of Organic Chemistry, 2010
- Generation of Thiocillin Variants by Prepeptide Gene Replacement and in Vivo Processing by Bacillus cereusJournal of the American Chemical Society, 2009
- Thiopeptide Biosynthesis Featuring Ribosomally Synthesized Precursor Peptides and Conserved Posttranslational ModificationsCell Chemical Biology, 2009
- A Robust Platform for the Synthesis of New Tetracycline AntibioticsJournal of the American Chemical Society, 2008
- Translational Regulation via L11: Molecular Switches on the Ribosome Turned On and Off by Thiostrepton and MicrococcinMolecular Cell, 2008
- A Post-PKS Oxidation of the Amphotericin B Skeleton Predicted to be Critical for Channel Formation Is Not Required for Potent Antifungal ActivityJournal of the American Chemical Society, 2007